NITI Aayog Panel to Drive AIIMS Modernization

NITI Aayog, the Indian government’s premier think tank, has established a committee to devise a roadmap for transforming AIIMS, New Delhi, into a world-class institution for medical research and healthcare excellence. Led by NITI Aayog member VK Paul, the committee will analyze current systems and propose reforms with specific timelines for their implementation. This initiative is part of a broader effort to enhance healthcare infrastructure, governance, and self-sufficiency in AIIMS.

Additionally, NITI Aayog has been working on Universal Health Coverage (UHC) and rare disease treatment affordability, partnering with CSEP Research Foundation to examine global UHC models. It has also facilitated the indigenous production of affordable drugs for rare diseases, significantly reducing treatment costs.

Key Highlights of AIIMS Transformation Panel

Committee Formation

  • Led by VK Paul, focusing on AIIMS New Delhi’s transformation.

Objectives

  • Assess current systems & propose reforms with clear timelines.
  • Improve patient inflow management and hospital governance.
  • Develop Key Performance Indicators (KPIs) for clinical, academic, and research excellence.
  • Enhance financial prudence & sustainability in AIIMS operations.

Focus Areas

  • Governance & transparency.
  • Research excellence.
  • Clinical & academic improvements.
  • Self-sufficiency & financial sustainability.

NITI Aayog’s Efforts on Universal Health Coverage (UHC)

  • Partnership with CSEP Research Foundation to study global UHC models.

Draft paper on healthcare financing strategies,

  • Addresses supply-side & demand-side financing.
  • Aims to improve healthcare accessibility, quality, and affordability.
  • Extensive government & stakeholder consultations planned to shape policies.

Rare Disease Drug Accessibility Initiative

  • Effort to provide affordable indigenous treatments for rare diseases.
  • 4 affordable drugs introduced, priced at 1/60th to 1/100th of imported versions.
  • 4 more drugs undergoing regulatory approval, expected to launch by year-end.
Summary/Static Details
Why in the news? NITI Aayog Panel to Drive AIIMS Modernization
AIIMS Transformation Panel Committee led by VK Paul to improve AIIMS systems, governance, and sustainability.
Key Focus Areas Patient inflow, KPIs, governance, financial sustainability, transparency.
Universal Health Coverage (UHC) Study NITI Aayog & CSEP Research Foundation examining global UHC models.
Healthcare Financing Reforms Addresses supply & demand-side financing to improve accessibility & affordability.
Affordable Rare Disease Drugs 4 drugs introduced at 1/60th to 1/100th of imported costs, 4 more in pipeline.
Shivam

Recent Posts

President Droupadi Murmu Gave Assent to Waqf (Amendment) Act, 2025

On April 5, 2025, President Droupadi Murmu gave her assent to the Waqf (Amendment) Act,…

12 hours ago

New Pamban Bridge Inaugurated by PM Modi

On April 6, 2025, Prime Minister Narendra Modi inaugurated the New Pamban Bridge in Tamil…

12 hours ago

SBI Clerk Mains GA Capsule 2025: Latest Updates & Important Topics PDF

The SBI Clerk Mains Exam 2025 is expected to be conducted in April 2025, and…

18 hours ago

Ram Navami 2025, When and Why is it Celebrated?

Ram Navami is a very special Hindu festival that celebrates the birth of Lord Ram.…

1 day ago

Seema Agrawal Named DGP of Fire and Rescue Services

Seema Agrawal, a senior Indian Police Service (IPS) officer, has been appointed as the new…

1 day ago

Tamil Nadu Sets New High with 9.69% Growth

Tamil Nadu has achieved the highest real economic growth rate in India for the year…

1 day ago